Danaher Corporation (DHR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$232.23 -2.00% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $231.95

Danaher Corporation (DHR) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (59% profit margin, 6% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- β€’ BUY Cap $166.72B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DHR Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is DHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Danaher Corporation (NYSE: DHR) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $232.23 (-2.00% 1D, market cap $166.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, DHR ranks #44 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does DHR compare to DE and TMO in the Industrials sector?
β–Ό

Within the Industrials sector (Industrial Machinery/Components), DHR carries a Roarable B- (70/100 RQD), trailing P/E of 46.1x, gross margin of 59.1%, and ROIC of 6.1%. By comparison, DE (Deere & Company) holds a C+ grade (66/100 RQD, P/E 35.4x, ROIC 9.3%, cap $177.95B) and TMO (Thermo Fisher Scientific Inc) posts a B grade (73/100 RQD, P/E 39.0x, ROIC 9.3%, cap $262.22B). Among the 5-stock peer group, ITW leads on earnings multiple (24.3x) while ITW leads on capital efficiency (23.4% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DHR?
β–Ό

Per DHR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000313616), Danaher Corporation generated $24.57B in revenue (+2.9% YoY), $3.61B in net income, and $5.26B in free cash flow against $83.46B in total assets and $18.42B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 46x earningsβ€”high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $231.95 (-0.12%)🧬 Cannibal Buyback (-0.96% YoY Shares)βš™οΈ Cash Engine: 13/20 (C) β€’ 21.4% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY β€’ 68.1% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERBUY β€’ B-
025507510070
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B Β· Rk C+
Cash (13)Whales (19)SEC (14)Macro (13)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE+5.4% Base Target
$289 Bull$245 Base$190 Bear
πŸ“¬ FREE DHR RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for DHR)Realized 20D OHLCV Swing Band: Β±5.8%
Deterministic 5-Pillar Attribution (70/100 Composite)
πŸ” WHY DHR SCORES 70/100 (B-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Whale & Options Positioning+19/20 pts (27% of score)

20D Institutional Volume Accumulation (Β±5.8% realized swing band)

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (20% of score)

Altman Z-Score 3.85 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 7/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution11/20 pts (-9 pt drag)

Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
62
Grade C+$222.84+0.6% Next Q
Q2 (-2Q)
65
Grade C+$224.24+3.5% Next Q
Q3 (-1Q)
67
Grade B-$232.00+0.1% Next Q
Current
70
Grade B-$232.23+6.6% Hist 90D Ξ±
Trajectory: C+ (62) β†’ B- (70)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the DHR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 70/100 (B-) score, DHR faces multiple-compression risk if 46.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 46x earningsβ€”high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) β€” any gross margin slip below 56.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($219.65) or 200D SMA ($201.10) invalidates the momentum regime and cuts Target Base ($244.77) toward Bear Floor ($190.43).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DHRβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œDHR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL β€’ FY 2025 (10-K)

How DHR Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$5.26B (21.4% FCF Margin)
Revenue$24.57BGross Profit $14.52B (59.1%)Cost of Sales $10.04BOp Profit $4.69B (19.1%)OpEx (R&D/SG&A) $9.83BNet Profit$3.61B (14.7%)Tax/Other $1.08B

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

β–  Revenueβ–  Net Profitβ–  Free Cash Flow
FY23
Rev $23.89B
FY24
Rev $23.88B
FY25
Rev $24.57B
Fiscal YearRevenueGross MarginOp MarginNet ProfitFree Cash FlowROIC %
FY 2025$24.57B59.1%19.1%$3.61B$5.26B6%
FY 2024$23.88B59.5%20.4%$3.90B$5.30B6.8%
FY 2023$23.89B59.1%21.8%$4.76B$6.09B7.4%
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DHR)

  • βœ“Walkthrough of DHR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DHR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +33.43%β–² ASCENDING CHANNEL
2026-11-02O $234.1H $237.0L $232.2C $232.2VOL 2.70M
RES: $239.2SUP: $173.9SMA50: $219.7SMA200: $201.1
$243.9$221.4$198.9$176.4$154.0RES $239.2SUP $173.9$232.22026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DHR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
34.2%/yr Implied 5Y Growth

vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DHR today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’
DHR β†’ NVO Analyst Hypothesis
Novo Nordisk $6B+ annual API manufacturing expansions utilize downstream purification chromatography resins and single-use filtration consumables where Danaher Cytiva and Pall hold leading bioprocess share.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DHR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DHR)

1. Head-to-Head Industrials Peer Comparison (DHR vs. DE, TMO, JCI, ITW)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Danaher Corporation (DHR) ranks #44 by composite RQD confidence (70/100, grade B-) and #6 by equity capitalization ($166.72B). Within this direct 5-issuer industry benchmark cohort, ITW leads on earnings valuation at 24.3x trailing P/E, while ITW leads on capital efficiency and profitability with 23.4% ROIC and 52.9% gross margin. ITW currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with DHR at 70/100 (B-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
DHR ACTIVE
Danaher Corporation
B- 70/100 46.1x 59.1% 6.1% -2.00% $166.72B Benchmark Subject
DE
Deere & Company
C+ 66/100 35.4x β€” 9.3% +2.35% $177.95B /de-vs-dhr β†’
TMO
Thermo Fisher Scientific Inc
B 73/100 39.0x β€” 9.3% -1.72% $262.22B /tmo-vs-dhr β†’
JCI
Johnson Controls International plc Ordinary Share
B 73/100 29.1x 36.4% 15.6% -5.84% $95.87B /jci-vs-dhr β†’
ITW
Illinois Tool Works Inc.
B+ 76/100 24.3x 52.9% 23.4% -1.01% $79.97B /itw-vs-dhr β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0000313616

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Danaher Corporation (DHR) reported GAAP revenue of $24.57B (+2.9% vs. FY2024 revenue of $23.88B , and +2.8% cumulative change since FY2023) , GAAP net income of $3.61B, operating cash flow of $6.42B, and free cash flow of $5.26B (-0.7% YoY). On the balance sheet, DHR closed FY2025 with $83.46B in total assets against $18.42B in total debt (Altman Z-Score: 3.85, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $24.57B $3.61B $6.42B $5.26B $83.46B $18.42B
FY2024 (FY) 2024-12-31 $23.88B $3.90B $6.69B $5.30B $77.54B $15.50B
FY2023 (FY) 2023-12-31 $23.89B $4.76B $7.16B $6.09B $91.70B $21.46B

3. DHR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Danaher Corporation (NYSE: DHR) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $232.23 (-2.00% 1D, market cap $166.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, DHR ranks #44 in composite RQD confidence.

How does DHR compare to DE and TMO in the Industrials sector?

Within the Industrials sector (Industrial Machinery/Components), DHR carries a Roarable B- (70/100 RQD), trailing P/E of 46.1x, gross margin of 59.1%, and ROIC of 6.1%. By comparison, DE (Deere & Company) holds a C+ grade (66/100 RQD, P/E 35.4x, ROIC 9.3%, cap $177.95B) and TMO (Thermo Fisher Scientific Inc) posts a B grade (73/100 RQD, P/E 39.0x, ROIC 9.3%, cap $262.22B). Among the 5-stock peer group, ITW leads on earnings multiple (24.3x) while ITW leads on capital efficiency (23.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DHR?

Per DHR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000313616), Danaher Corporation generated $24.57B in revenue (+2.9% YoY), $3.61B in net income, and $5.26B in free cash flow against $83.46B in total assets and $18.42B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 46x earningsβ€”high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DHR trading relative to its 50-day, 200-day, and 52-week technical levels?

DHR last traded at $232.23 (-2.00% on volume of 3,755,006 shares), positioning the stock +5.73% above its 50-day simple moving average ($219.65) and +15.48% above its 200-day simple moving average ($201.10). Across its 52-week range of $160.93 to $242.80, DHR sits at the 87.1% percentile with a 14-day RSI of 62.5 (BULLISH MOMENTUM) and an implied next-earnings move of Β±5.8% ($218.76 to $245.70).

DHR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

How profitable is Danaher Corporation (DHR)?

In FY 2025 (10-K), DHR converted $24.6B of revenue into a 59.1% gross margin, 19.1% operating margin, and $5.3B in free cash flow (21.4% FCF margin).

ROARABLE RATING BRIEF β€’ RQD 70/100 (B-) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

DHR β€” Danaher Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:09:18Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, DHR scores 70 out of 100, a B- grade labeled "Roarable Buy β€” Sound Institutional Accumulation." The five pillars are: Fundamental Cash Engine at 13/20 (ROIC 6.1%; FCF yield 3.15%), Whale 13F Flow at 19/20 (institutional accumulation and options positioning), Insider Conviction at 11/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (Beta 0.9; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 3.85; Piotroski F 7/9; Debt/Equity 0.35).

For a prospective investor, the strongest pillar is institutional flow, which the rating places near its maximum. The cash-generation and macro-fit pillars sit in the middle of the range, and the ROIC and FCF yield figures signal that the valuation is rich relative to current cash returns. Per the market data, the P/E (TTM) is 46.1 and the forward P/E is 42.9, so upside depends heavily on earnings growth materializing rather than on multiple support. The forensic balance sheet is comparatively sound per the rating's inputs. Insider conviction is moderate. This is an educational reading of the scores, not personalized advice.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
236.98$166.72B46.142.930.95.140.53%0.9$160.93 - $242.86.1%

Business

Per the profile, Danaher Corporation is a NYSE-listed issuer in the Industrials sector, specifically Industrial Machinery/Components. Per the Butterfly Supply-Chain Graph, the Biotechnology Segment's bioprocessing business is referenced as a supplier of chromatography resins and single-use filtration consumables. Not available in source data for the detailed product lines, customer base beyond the referenced Novo Nordisk relationship, or revenue mix by segment.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the headlines include a Yahoo Finance report on a recovery in pricing, a Seeking Alpha report describing a drop after a Q3 revenue miss amid a CEO transition (flagged RED / RISK WATCH), a Yahoo Finance report questioning the valuation, a Benzinga report on same-day stock movement, a Simply Wall St forecast piece, and a Stock Titan report on an EVP's sale of 15,603 shares after exercising options at $76.47 per share. The Q3 revenue miss and CEO transition are the principal risk-watch items. Per the Butterfly Supply-Chain Graph, one analyst-hypothesis link (evidence tier: ANALYST_HYPOTHESIS) connects DHR to NVO through a DIRECT_SUPPLIER relationship with a TAILWIND direction, with the next catalyst listed as the Danaher Biotechnology Segment Bioprocessing Consumables Order Book-to-Bill print. Proprietary signals are empty per the graph. The exposure percentage is undisclosed.

Open Questions

  • What is the current consensus analyst rating and price target, given that analyst data is absent from the sources?
  • What are the actual 13F institutional holder names and share changes behind the Whale Flow pillar score of 19/20?
  • What was the scope and magnitude of the Q3 revenue miss and CEO transition referenced in the news feed?
  • What are the reported EPS and cash balances for each fiscal period, which are currently N/A in the financials?
  • What is the exposure percentage of DHR's bioprocessing business to the GLP-1 supply chain, which the graph lists as undisclosed?

DHR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Danaher Corporation (DHR) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to DHR Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DHR Bull vs. Bear Conversation Board β€” What's Your Call at $232.23?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DHR 🐻 33% BEARISH CONVICTION
1. Pick Your Side on DHR:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk πŸ‚ BULLISH 🎯 Target: $279.64 (+18.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is DHR (B- β€’ RQD 70/100) a Buy at $236.98?

Welcome to the DHR (Danaher Corporation) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy β€” Sound Institutional Accumulation) in Industrial Machinery/Components. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (46.1x trailing P/E). Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $191.95 (-19.0%)
Spot @ $236.98

Pump the brakes on DHR β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on DHR, but look at what you are paying: 46.1x trailing P/E with 59.1% gross margins. Unless Danaher Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $277.27 (+17.0%)
Spot @ $236.98

DHR cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on DHR, the market is fixating on short-term headline noise in Industrial Machinery/Components and ignoring the balance sheet and cash flow trajectory. At $236.98 (52-wk range $160.93 - $242.80), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%